InvestorQ : Why was Jubilant Pharma seeing so much of positive action on 19 April?
Niti Shenoi made post

Why was Jubilant Pharma seeing so much of positive action on 19 April?

Answer
image
ishika Banerjee answered.
3 weeks ago
Follow

Jubilant Pharmova is the pharmaceutical subsidiary of the Jubilant Group, which was formerly referred to as Jubilant Life Sciences. The stock rallied by over 10% after it announced an oral version of Remdesevir. This is the drug that is used to treat COVID-19 and which has been facing a tremendous shortage in India in last few weeks.

Jubilant Pharmova has also sought approval from the Drug Controller General of India or DCGI for the same. The idea of this new drug is to have an affordable and convenient drug that is orally administered. This assumes importance since Remdesevir is in short supply across most locations. Jubilant has a licensing agreement with Gilead Inc of the US.

0 Views